| |
Bradykinin (1-7)  |
|
|
| Cat. No. |
Size |
Price |
Figures |
|---|
RP11133-5 mg
| 5 mg | $ 23.75 | HPLC: 20050919140131 (PDF)
MASS SPECE: 20050919140153 (PDF)
MSDS: 20080922041720 (PDF)
References:
- Campbell DJ, et al. Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice. Hypertension. Apr 2004; 43(4):854-859.
- Xiao HD, et al. Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. Am. J. Pathol. Sep 2004; 165(3):1019-1032.
- Colquhoun DR, et al. Detection of norovirus capsid protein in authentic standards and in stool extracts by matrix-assisted laser desorption ionization and nanospray mass spectrometry. Appl. Environ. Microbiol. Apr 2006; 72(4):2749-2755.
|
|---|
RP11133-25 mg
| 25 mg | $ 95.00 |
|---|
| Full Name | |
Sequence
(one-letter code) |
RPPGFSP | Sequence
(three-letter code) | {ARG}{PRO}{PRO}{GLY}{PHE}{SER}{PRO} |
|---|
| Description | Bradykinin is an activates pain receptors. Bradykinin induces smooth muscle contraction; activates Ca2+-dependent nitric oxide synthetase. Bradykinin can also increase capillary permeability. Bradykinin is a potent stimulator of nitric oxide formation by vascular endothelium. Bradykinin also stimulates prostacyclin formation. |
|---|
| Formula | C35H52N10O9 |
|---|
| M.W. | 756.9 |
|---|
| Cas | 23815-87-4 |
|---|
| Purity | > 95% |
|---|
| Storage | Store at -20°C. |
|
